Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Earn travel points effortlessly with Visa cards that have no fees. Discover options that help you travel more for less!
23,594 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
This article breaks down agilysys (agys) 2026 earnings, explaining what the metrics mean for investors. Learn how to ...
A synthetic contract puts SpaceX at a $2.4 trillion implied IPO, a figure that dwarfs Facebook's listing and tests ho...
XRP faces renewed volatility as liquidity on major exchanges tightens to levels not seen since 2020. Traders weigh ET...
Synopsys sits at the core of AI driven chip design as investors weigh a path to $700 this year. A debt load from the ...
As TopBuild (BLD) closes 2025, investors look for how revenue, margins, and backlog shape the 2026 outlook. This arti...
With the housing market cooling, investors are redirecting capital toward durable infrastructure plays. This report e...
Lenders confront tight margins and a data gap that can hide risk. The danger single-bureau blind spot underscores why...
As IPO chatter heats up in 2026, SpaceX faces a pivotal moment. The CFO’s quiet leadership could define the deal, unl...
CoreWeave has turbocharged its AI compute backlog ahead of a Nasdaq-100 debut, placing the stock under fresh scrutiny...
Investors are rethinking AI exposure as OpenAI speeds up monetization and questions about platform risk surface. The ...
Credit models are evolving as BNPL usage, rent payment history, and trended data tighten the grip on underwriting. Th...